Phagenyx Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 81

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

Phagenyx General Information

Description

Developer of a medical device designed to provide treatment of acute dysphagia. The company's device helps harness the brain's capacity for relearning functions that have been lost through brain damage via neuroplasticity or cortical remapping through neurostimulation therapy and offers a non-surgical, personalized treatment using pharyngeal electrical stimulation (PES), enabling patients to restore the neurological control of swallowing and accelerate recovery.

Contact Information

Website
www.phagenesis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 18 Enterprise House
  • Manchester Science Park
  • Manchester M16 6SE
  • England, United Kingdom
+44 0161
Primary Industry
Therapeutic Devices
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Unit 18 Enterprise House
  • Manchester Science Park
  • Manchester M16 6SE
  • England, United Kingdom
+44 0161

Phagenyx Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Phagenyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Secondary Transaction - Private 01-Apr-2026 Completed Generating Revenue
9. Later Stage VC 29-Aug-2025 Completed Generating Revenue
8. Merger/Acquisition Cancelled Generating Revenue
7. Later Stage VC 30-Aug-2024 Completed Generating Revenue
6. Accelerator/Incubator 07-Jun-2022 Completed Generating Revenue
5. Later Stage VC (Series C) 31-Aug-2016 Completed Generating Revenue
4. Later Stage VC (Series B) 22-May-2013 Completed Generating Revenue
3. Grant 22-May-2012 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Sep-2010 $3.13M $3.13M Completed Startup
1. University Spin-Out 10-Jul-2007 Completed Startup
To view Phagenyx’s complete valuation and funding history, request access »

Phagenyx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D3
Series D1
Series D2
Series D1
Series Z
Common Ordinary
Series C
Series B
Series B 898,523 $0.013437 $15.17 $15.17 1x $15.17 15.94%
Common Ordinary 87,250 $0.013437 $15.17 $15.17 1x $15.17 1.55%
To view Phagenyx’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Phagenyx Patents

  • 146

    Total Documents Applications and Grants

  • Total Patents Families

  • 88

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Phagenyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240082569-A1 Devices, systems, and methods for treating disease using electrical stimulation Pending 14-Sep-2022
US-20220313981-A1 Pharyngeal electrical stimulation devices, systems, and methods Pending 06-Apr-2021
US-20220160537-A1 Devices, systems, and methods for treating disease using electrical stimulation Inactive 24-Nov-2020
CA-3202129-A1 Devices, systems, and methods for securing treatment members Pending 20-Nov-2020
EP-4247471-A1 Devices, systems, and methods for securing treatment members Pending 20-Nov-2020 A61M25/02
To view Phagenyx’s complete patent history, request access »

Phagenyx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Phagenyx Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aphelion Corporation Minority
British Business Bank Lender/Debt Provider Minority
Nestle UK Corporation Minority
Northern Gritstone Venture Capital Minority
Sectoral Asset Management Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Phagenyx Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Phagenesis Germany Neuss, Germany 2021
PHAGENESIS Austria Vienna, Austria 2021

Phagenyx FAQs

  • When was Phagenyx founded?

    Phagenyx was founded in 2007.

  • Where is Phagenyx headquartered?

    Phagenyx is headquartered in Manchester, United Kingdom.

  • What is the size of Phagenyx?

    Phagenyx has 81 total employees.

  • What industry is Phagenyx in?

    Phagenyx’s primary industry is Therapeutic Devices.

  • Is Phagenyx a private or public company?

    Phagenyx is a Private company.

  • What is Phagenyx’s current revenue?

    The current revenue for Phagenyx is .

  • How much funding has Phagenyx raised over time?

    Phagenyx has raised $90.1M.

  • Who are Phagenyx’s investors?

    Aphelion, British Business Bank, Nestle UK, Northern Gritstone, and Sectoral Asset Management are 5 of 8 investors who have invested in Phagenyx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process